Ventric Health Company Profile

Background

Overview

Ventric Health is a healthcare technology company specializing in cardiovascular health, focusing on the early detection and management of heart failure. The company has developed the Vivio System™, a non-invasive device designed to diagnose heart failure within both clinical and home healthcare environments. Vivio utilizes advanced algorithms to detect elevated left ventricular end-diastolic pressure (LVEDP), a key indicator of heart failure, in under five minutes.

Mission and Vision

Mission: To create non-invasive heart diagnostic solutions that quickly deliver the insights value-based care organizations need to reduce costs and improve patient lives.

Vision: To bring non-invasive cardiovascular testing to everyone.

Industry Significance

Heart failure affects approximately 6.5 million people in the U.S., with an additional 550,000 new cases diagnosed each year. Early detection is crucial, yet up to 50% of heart failure patients remain undiagnosed, and diagnosis can be delayed by up to 30 months following the initial onset of symptoms. Ventric Health's Vivio System addresses this gap by enabling rapid, non-invasive diagnosis, potentially transforming the management of heart failure and reducing associated healthcare costs.

Key Strategic Focus

Core Objectives

Early Detection: Facilitate the prompt identification of heart failure to enable timely intervention.

Non-Invasive Diagnosis: Provide a non-invasive alternative to traditional diagnostic methods, enhancing patient comfort and accessibility.

Healthcare Accessibility: Expand access to heart failure diagnostics across various healthcare settings, including primary care and home healthcare environments.

Areas of Specialization

Cardiovascular Diagnostics: Development of devices and solutions for the early detection and management of heart failure.

Value-Based Care Support: Offering tools that assist healthcare providers in delivering cost-effective and patient-centered care.

Key Technologies Utilized

Advanced Algorithms: Employing sophisticated algorithms to analyze physiological data for accurate heart failure detection.

Mobile Health Solutions: Integrating mobile technology to enhance the portability and usability of diagnostic tools.

Primary Markets Targeted

Primary Care Providers: Enabling early detection of heart failure in primary care settings.

Home Healthcare Services: Facilitating remote monitoring and diagnosis for patients receiving home-based care.

Value-Based Care Organizations: Supporting healthcare systems focused on improving patient outcomes while controlling costs.

Financials and Funding

Funding History

Ventric Health has secured significant funding to support its growth and product development. In October 2023, the company received $8 million in seed funding to expand its virtual cardiology care network.

Recent Funding Rounds

October 2023: Secured $8 million in seed funding to enhance its heart failure management therapeutic model.

Notable Investors

The funding round was led by RA Capital Management, Waterline Ventures, and other investors.

Utilization of Capital

The capital is intended to expand Ventric Health's virtual cardiology care network, enhance the Vivio System, and support the company's mission to improve access to heart failure diagnostics and management.

Pipeline Development

Vivio System

Stage: FDA 510(k) clearance obtained in October 2023.

Target Conditions: Heart failure, specifically the detection of elevated LVEDP.

Anticipated Milestones: Ongoing efforts to integrate Vivio into various healthcare settings, including primary care and home healthcare environments.

Technological Platform and Innovation

Proprietary Technologies

Vivio System: A mobile, tech-enabled device that non-invasively measures elevated LVEDP, aiding in the diagnosis of heart failure.

Significant Scientific Methods

Advanced Algorithms: Utilized to analyze physiological data for accurate heart failure detection.

Non-Invasive Measurement Techniques: Employing a blood pressure cuff and single-lead Bluetooth-enabled ECG to assess LVEDP without invasive procedures.

Leadership Team

Key Executives

Sean Brady: Co-founder and CEO.

Derek Rinderknecht: Co-founder and CTO.

Niema Pahlevan: Co-founder.

Dr. Tom Cheek: Chief Medical Officer.

Jeff Cushler: Chief Information Officer.

Erin Brenner: Chief Operating Officer.

Dave Silvey: Vice President, Business Operations & People.

Tony Viole: Vice President, Operations.

Morteza Gharib: Co-founder.

Leadership Changes

In October 2023, Ventric Health appointed Christopher Abbott, a managed care veteran with over 25 years of experience, to its Board of Directors.

Competitor Profile

Market Insights and Dynamics

The cardiovascular diagnostics market is experiencing significant growth, driven by the increasing prevalence of heart failure and the need for early detection solutions. Innovations like the Vivio System are poised to transform the landscape by offering non-invasive, accessible diagnostic options.

Competitor Analysis

Heartbeat Health: Focuses on virtual cardiology services, providing remote consultations and monitoring.

Novocardia: Specializes in digital health solutions for cardiovascular care, including remote monitoring and telehealth services.

Luscii: Offers a platform for remote patient monitoring, integrating with various medical devices to track patient health metrics.

Strategic Collaborations and Partnerships

Ventric Health collaborates with value-based care organizations, primary care practices, and payer partners to expand the reach and impact of the Vivio System. These partnerships aim to integrate Vivio into diverse healthcare settings, enhancing early detection and management of heart failure.

Operational Insights

Ventric Health's non-invasive approach to heart failure diagnosis offers a competitive advantage by reducing the need for traditional, invasive procedures. The portability and ease of use of the Vivio System enable its deployment in various settings, including primary care and home healthcare, differentiating it from competitors that may rely on more centralized or invasive diagnostic methods.

Strategic Opportunities and Future Directions

Ventric Health is well-positioned to expand its market presence by leveraging its innovative technology to address the growing demand for accessible heart failure diagnostics. Future directions include broadening partnerships with healthcare providers, enhancing the Vivio System's capabilities, and exploring international markets to further its mission of improving cardiovascular health outcomes.